IRADIMED CORPORATION (NASDAQ:IRMD) Goes Ex-Dividend Soon
IRADIMED CORPORATION (NASDAQ:IRMD) Goes Ex-Dividend Soon
IRADIMED CORPORATION (NASDAQ:IRMD) stock is about to trade ex-dividend in three days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. Therefore, if you purchase IRADIMED's shares on or after the 20th of August, you won't be eligible to receive the dividend, when it is paid on the 30th of August.
IRADIMED CORPORATION(纳斯达克股票代码:IRMD)的股票即将在三天后进行除息交易。除息日是记录日期前的一个工作日,这是股东在公司账簿上有资格获得股息的截止日期。除息日是需要注意的重要日期,因为在该日或之后购买的任何股票都可能意味着延迟结算,而结算日期并未显示在记录日期。因此,如果你在8月20日当天或之后购买IRADIMED的股票,你将没有资格获得股息,当股息是根据8月份的3万亿美元支付的。
The company's next dividend payment will be US$0.15 per share, on the back of last year when the company paid a total of US$1.08 to shareholders. Calculating the last year's worth of payments shows that IRADIMED has a trailing yield of 2.4% on the current share price of US$45.13. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. As a result, readers should always check whether IRADIMED has been able to grow its dividends, or if the dividend might be cut.
该公司的下一次股息将为每股0.15美元,去年该公司向股东共支付了1.08美元。计算去年的付款额表明,IRADIMED的尾随收益率为2.4%,而目前的股价为45.13美元。股息是许多股东的重要收入来源,但业务的健康状况对于维持这些股息至关重要。因此,读者应始终检查IRADIMED是否能够增加其股息,或者股息是否可能被削减。
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. IRADIMED paid out just 20% of its profit last year, which we think is conservatively low and leaves plenty of margin for unexpected circumstances. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Over the last year, it paid out more than three-quarters (76%) of its free cash flow generated, which is fairly high and may be starting to limit reinvestment in the business.
股息通常从公司收入中支付,因此,如果公司支付的股息超过其收入,则其股息被削减的风险通常更高。去年,IRADIMED仅支付了其利润的20%,我们认为这是保守的低水平,为意外情况留下了充足的利润。话虽如此,即使是高利润的公司有时也可能无法产生足够的现金来支付股息,这就是为什么我们应该始终检查股息是否由现金流支付。去年,它支付了其产生的自由现金流的四分之三(76%)以上,这相当高,可能开始限制对该业务的再投资。
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
令人鼓舞的是,股息由利润和现金流共同支付。这通常表明,只要收益不急剧下降,股息是可持续的。
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
点击此处查看该公司的派息率,以及分析师对其未来股息的估计。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240816/0-2d2c006d69d36ff1fb00e51a169a7a8f-0-39bd49df15384a2468e287a250315730.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增长吗?
Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. It's encouraging to see IRADIMED has grown its earnings rapidly, up 20% a year for the past five years.
实现可持续收益增长的公司的股票通常具有最佳的股息前景,因为收益上升时更容易提高股息。如果业务陷入低迷并削减股息,该公司的价值可能会急剧下降。令人鼓舞的是,IRADIMED的收益迅速增长,在过去五年中每年增长20%。
Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. IRADIMED has delivered an average of 1.4% per year annual increase in its dividend, based on the past two years of dividend payments. Earnings per share have been growing much quicker than dividends, potentially because IRADIMED is keeping back more of its profits to grow the business.
许多投资者将通过评估股息支付在一段时间内发生了多大变化来评估公司的股息表现。根据过去两年的股息支付,IRADIMED的股息平均每年增长1.4%。每股收益的增长速度远快于股息,这可能是因为IRADIMED保留了更多的利润来发展业务。
The Bottom Line
底线
Has IRADIMED got what it takes to maintain its dividend payments? Earnings per share have grown at a nice rate in recent times and over the last year, IRADIMED paid out less than half its earnings and a bit over half its free cash flow. There's a lot to like about IRADIMED, and we would prioritise taking a closer look at it.
IRADIMED 有维持股息支付所需的条件吗?最近,每股收益以不错的速度增长,在过去的一年中,IRADIMED支付的收益不到一半,自由现金流略高于一半。IRADIMED 有很多值得喜欢的地方,我们会优先仔细研究它。
On that note, you'll want to research what risks IRADIMED is facing. To that end, you should learn about the 3 warning signs we've spotted with IRADIMED (including 1 which is concerning).
关于这一点,你需要研究IRADIMED面临哪些风险。为此,你应该了解我们在IRADIMED中发现的3个警告信号(包括一个令人担忧的信号)。
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
一个常见的投资错误是买入你看到的第一只有趣的股票。在这里你可以找到高收益股息股票的完整清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。